SG Americas Securities’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

SG Americas Securities’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,143	Closed	-$123K	–	3505
2022 Q3	$123K	Buy	+6,143	New	+$81K	﹤0.01%	2695
2022 Q1	–	Sell	-9,935	Closed	-$141K	–	3625
2021 Q4	$141K	Sell	9,935 -13,887	-58%	-$240K	﹤0.01%	2866
2021 Q3	$552K	Buy	+23,822	New	+$563K	﹤0.01%	2401
2021 Q2	–	Sell	-6,706	Closed	-$188K	–	3368
2021 Q1	$188K	Buy	+6,706	New	+$242K	﹤0.01%	2709

SG Americas Securities's FMTX Position: Q4 2022 in Review

SG Americas Securities sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 6,143 shares — an estimated $123K sold.

SG Americas Securities first reported a position in FMTX in Q1 2021 and held it in 4 quarters. The position peaked at $552K in Q3 2021. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

SG Americas Securities reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
SG Americas Securities sold 6,143 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $123K.
SG Americas Securities first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
SG Americas Securities's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $552K in Q3 2021.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on SG Americas Securities's 13F filing for Q4 2022, filed 2 Feb 2023.